Skip to main content

Compare Stocks

Date Range: 

 Scholar RockCoherus BioSciencesVaxcyteCurisCortexyme
SymbolNASDAQ:SRRKNASDAQ:CHRSNASDAQ:PCVXNASDAQ:CRISNASDAQ:CRTX
Price Information
Current Price$28.60$13.85$18.67$16.27$36.57
52 Week RangeBuyBuyBuyBuyHold
MarketRank™
Overall Score1.51.41.70.91.3
Analysis Score3.53.43.51.53.1
Community Score2.32.52.92.62.6
Dividend Score0.00.00.00.00.0
Ownership Score0.80.01.70.00.8
Earnings & Valuation Score0.61.30.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$61.60$25.00$48.00$14.60$50.00
% Upside from Price Target115.38% upside80.57% upside157.10% upside-10.26% downside36.72% upside
Trade Information
Market Cap$983.64 million$1.05 billion$958.80 million$1.49 billion$1.08 billion
Beta0.351.57N/A3.290.95
Average Volume288,0051,226,465371,5202,603,553280,174
Sales & Book Value
Annual Revenue$20.49 million$356.07 millionN/A$10 millionN/A
Price / Sales48.012.95N/A148.90N/A
CashflowN/A$1.04 per shareN/AN/AN/A
Price / CashN/A13.36N/AN/AN/A
Book Value$3.80 per share$1.50 per shareN/A($1.02) per share$4.30 per share
Price / Book7.539.23N/A-15.95N/A
Profitability
Net Income$-51,000,000.00$89.83 million$-50,270,000.00$-32,140,000.00$-36,980,000.00
EPS($1.85)$1.23N/A($0.86)($1.94)
Trailing P/E RatioN/A6.790.00N/AN/A
Forward P/E RatioN/A15.73N/AN/AN/A
P/E GrowthN/A9.34N/AN/AN/A
Net Margins-365.84%33.06%N/A-279.33%N/A
Return on Equity (ROE)-80.16%90.98%N/AN/A-37.78%
Return on Assets (ROA)-41.33%27.33%N/A-81.32%-35.24%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.58%N/AN/AN/A
Current Ratio3.63%5.45%10.12%3.10%8.71%
Quick Ratio3.63%5.18%10.12%3.10%8.71%
Ownership Information
Institutional Ownership Percentage61.87%N/A74.08%34.66%55.48%
Insider Ownership Percentage24.60%15.86%N/A7.34%19.80%
Miscellaneous
Employees119310582837
Shares Outstanding34.39 million75.75 million51.36 million91.52 million29.59 million
Next Earnings Date5/13/2021 (Estimated)8/5/2021 (Estimated)8/11/2021 (Estimated)5/12/2021 (Confirmed)8/16/2021 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
Cortexyme Provides Business Update and Reports First Quarter 2021 Results - Yahoo FinanceCortexyme Provides Business Update and Reports First Quarter 2021 Results - Yahoo Finance
finance.yahoo.com - May 12 at 9:00 PM
Cortexyme, Inc. (NASDAQ:CRTX) CEO Casey Lynch Sells 30,000 SharesCortexyme, Inc. (NASDAQ:CRTX) CEO Casey Lynch Sells 30,000 Shares
americanbankingnews.com - May 12 at 5:06 PM
Cortexyme (NASDAQ:CRTX) Releases Quarterly  Earnings Results, Misses Estimates By $0.08 EPSCortexyme (NASDAQ:CRTX) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS
americanbankingnews.com - May 11 at 3:22 PM
Cortexyme (NASDAQ:CRTX) Trading Up 6.8%Cortexyme (NASDAQ:CRTX) Trading Up 6.8%
americanbankingnews.com - May 11 at 11:42 AM
How Much Are Cortexyme, Inc. (NASDAQ:CRTX) Insiders Spending On Buying Shares? - Yahoo FinanceHow Much Are Cortexyme, Inc. (NASDAQ:CRTX) Insiders Spending On Buying Shares? - Yahoo Finance
finance.yahoo.com - May 10 at 9:34 PM
Cortexyme EPS beats by $0.02 - Seeking AlphaCortexyme EPS beats by $0.02 - Seeking Alpha
seekingalpha.com - May 10 at 9:34 PM
Cortexyme Posts Q1 Loss Per Share $0.78 - CMLViz.com - CML NewsCortexyme Posts Q1 Loss Per Share $0.78 - CMLViz.com - CML News
cmlviz.com - May 10 at 4:33 PM
Cortexyme Provides Business Update and Reports First Quarter 2021 Results - BioSpaceCortexyme Provides Business Update and Reports First Quarter 2021 Results - BioSpace
biospace.com - May 10 at 4:33 PM
Cortexyme Provides Business Update and Reports First Quarter 2021 ResultsCortexyme Provides Business Update and Reports First Quarter 2021 Results
finance.yahoo.com - May 10 at 4:33 PM
How Much Are Cortexyme, Inc. (NASDAQ:CRTX) Insiders Spending On Buying Shares?How Much Are Cortexyme, Inc. (NASDAQ:CRTX) Insiders Spending On Buying Shares?
finance.yahoo.com - May 9 at 11:45 AM
Checking In On Cortexyme - Seeking AlphaChecking In On Cortexyme - Seeking Alpha
seekingalpha.com - May 6 at 4:50 PM
Checking In On CortexymeChecking In On Cortexyme
seekingalpha.com - May 6 at 2:15 PM
Is Cortexyme Inc (CRTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserverIs Cortexyme Inc (CRTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver
investorsobserver.com - May 4 at 3:10 PM
Cortexyme (NASDAQ:CRTX) Stock Price Down 7.4%Cortexyme (NASDAQ:CRTX) Stock Price Down 7.4%
americanbankingnews.com - May 4 at 1:16 PM
Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021 - Yahoo FinanceCortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021 - Yahoo Finance
finance.yahoo.com - May 4 at 10:10 AM
Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021
finance.yahoo.com - May 4 at 10:10 AM
Cortexyme (NASDAQ:CRTX) Shares Gap Down to $38.26Cortexyme (NASDAQ:CRTX) Shares Gap Down to $38.26
americanbankingnews.com - April 26 at 12:10 PM
Where Does Cortexyme Inc (CRTX) Stock Fall in the Biotechnology Field After It Has Risen 8.93% This Week? - InvestorsObserverWhere Does Cortexyme Inc (CRTX) Stock Fall in the Biotechnology Field After It Has Risen 8.93% This Week? - InvestorsObserver
investorsobserver.com - April 21 at 2:09 PM
Should You Buy Cortexyme Inc (CRTX) Stock After it Is Up 6.92% in a Week? - InvestorsObserverShould You Buy Cortexyme Inc (CRTX) Stock After it Is Up 6.92% in a Week? - InvestorsObserver
investorsobserver.com - April 20 at 2:04 PM
Cortexyme (NASDAQ:CRTX) Stock Price Up 4.5%Cortexyme (NASDAQ:CRTX) Stock Price Up 4.5%
americanbankingnews.com - April 20 at 11:58 AM
Cortexyme Inc (CRTX) is down -0.97% in a Week, Should You Sell? - InvestorsObserverCortexyme Inc (CRTX) is down -0.97% in a Week, Should You Sell? - InvestorsObserver
investorsobserver.com - April 13 at 3:10 PM
Where Will Cortexyme Inc (CRTX) Stock Go Next After It Is Lower By 6.77% in a Week? - InvestorsObserverWhere Will Cortexyme Inc (CRTX) Stock Go Next After It Is Lower By 6.77% in a Week? - InvestorsObserver
investorsobserver.com - April 9 at 8:01 PM
Is Cortexyme Inc (CRTX) a Stock to Watch After Losing -3.90% This Week? - InvestorsObserverIs Cortexyme Inc (CRTX) a Stock to Watch After Losing -3.90% This Week? - InvestorsObserver
investorsobserver.com - March 31 at 3:32 PM
Cortexyme Inc (CRTX) Stock Is Up 0.71% This Week: Buy, Hold, or Sell? - InvestorsObserverCortexyme Inc (CRTX) Stock Is Up 0.71% This Week: Buy, Hold, or Sell? - InvestorsObserver
investorsobserver.com - March 26 at 3:02 PM
Thursday 3/25 Insider Buying Report: CRTXThursday 3/25 Insider Buying Report: CRTX
marketwatch.com - March 26 at 4:48 AM
DateCompanyBrokerageAction
1/25/2021Scholar RockBMO Capital MarketsBoost Price Target
1/21/2021Scholar RockWedbushBoost Price Target
1/11/2021Scholar RockCredit Suisse GroupInitiated Coverage
1/6/2021Scholar RockJPMorgan Chase & Co.Initiated Coverage
10/27/2020Scholar RockRobert W. BairdReiterated Rating
11/19/2019Scholar RockCowenReiterated Rating
6/18/2018Scholar RockJefferies Financial GroupInitiated Coverage
5/7/2021Coherus BioSciencesMaxim GroupInitiated Coverage
5/7/2021Coherus BioSciencesHC WainwrightLower Price Target
2/25/2021Coherus BioSciencesCitigroupLower Price Target
11/19/2020Coherus BioSciencesMizuhoLower Price Target
7/16/2020Coherus BioSciencesBank of AmericaInitiated Coverage
4/17/2020Coherus BioSciencesSunTrust BanksInitiated Coverage
8/12/2019Coherus BioSciencesBarclaysSet Price Target
8/14/2020VaxcyteNeedham & Company LLCReiterated Rating
7/7/2020VaxcyteCantor FitzgeraldInitiated Coverage
3/30/2021CurisB. RileyInitiated Coverage
3/17/2021CurisJonestradingBoost Price Target
7/29/2020CurisLaidlawInitiated Coverage
12/11/2020CortexymeSmith Barney CitigroupInitiated Coverage
12/11/2020CortexymeCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated Coverage
9/24/2020CortexymeLifesci CapitalReiterated Rating
5/13/2020CortexymeCanaccord GenuityReiterated Rating
6/3/2019CortexymeJMP SecuritiesInitiated Coverage
(Data available from 5/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.